Karin Rexroad peeks through the bore of the PET-CT scanner at LMH Health. Positron emission tomography, or PET, scans have long been used to diagnose cancer and determine how far it has progressed.

Patients in East Texas now have access to a new, advanced form of heart-imaging technology that physicians say can provide clearer, more accurate evaluations of blood flow to the heart and help detect ...

LUFKIN, Texas (KTRE) - Advanced Cardiology and Electrophysiology in Lufkin is now the first clinic in East Texas to offer cardiac PET/CT scanning - a technology that uses Positron Emission Tomography ...

GE HealthCare GEHC recently unveiled new advancements in precision cardiac care at the 2025 SNMMI annual meeting in New Orleans, with a spotlight on Flyrcado—its FDA-approved Positron Emission ...

The U.S. Food and Drug Administration (FDA) has approved flurpiridaz F-18 (Flyrcado; GE Healthcare), a first-of-its-kind positron emission tomography (PET) imaging agent, for use in adult patients ...

Please provide your email address to receive an email when new articles are posted on . A strategy involving shared cardiac PET scans and frequent follow-up improved CV risk and outcomes vs. standard ...

The National Institutes of Health (NIH) has released a major study showing how positron emission tomography (PET) scans of the heart could be used to find people likely to get Parkinson’s disease or ...

Niagara Falls, NY, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular imaging medical device company offering PET and PET-CT ...

Armed with new phase 3 data, Bayer is preparing to file for approval of a new PET imaging agent that could accelerate the ...

Bayer announced positive topline results from the phase III REVEAL study, an investigator-initiated study by Brigham and Women’s Hospital that evaluated the investigational PET/CT radiotracer I 124 ...